Literature DB >> 3899842

Treatment of Clostridium difficile colitis.

J G Bartlett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899842     DOI: 10.1016/0016-5085(85)90227-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  12 in total

1.  Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

Authors:  F Barbut; A Richard; K Hamadi; V Chomette; B Burghoffer; J C Petit
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Clostridium difficile colitis in children with cystic fibrosis.

Authors:  Sunny Zaheed Hussain; Cathy Chu; David P Greenberg; David Orenstein; Seema Khan
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

3.  Clostridium difficile in an oncology unit.

Authors:  A L Brunetto; A D Pearson; A W Craft; S J Pedler
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

Review 4.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Nutritional aspects of cytotoxin production by Clostridium difficile.

Authors:  D P Osgood; N P Wood; J F Sperry
Journal:  Appl Environ Microbiol       Date:  1993-12       Impact factor: 4.792

6.  Pseudomembranous colitis: how useful is endoscopy?

Authors:  J M Bergstein; A Kramer; D H Wittman; C Aprahamian; E J Quebbeman
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

Review 7.  Clostridium difficile infection: a common clinical problem for the general internist.

Authors:  G M Caputo; M R Weitekamp; A E Bacon; C Whitener
Journal:  J Gen Intern Med       Date:  1994-09       Impact factor: 5.128

Review 8.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.

Authors:  F Biavasco; E Manso; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

10.  Antibiotic-associated colitis and cystic fibrosis.

Authors:  C S Pokorny; P T Bye; C MacLeod; W S Selby
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.